Dolby Laboratories Inc.

NYSE: DLB · Real-Time Price · USD
72.46
-0.07 (-0.10%)
At close: Aug 15, 2025, 10:23 AM

Dolby Laboratories Balance Sheet Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 27, 2024 Sep 29, 2023 Sep 30, 2022 Sep 24, 2021
Cash & Equivalents
482.05M 745.36M 620.13M 1.23B
Short-Term Investments
n/a 139.15M 189.21M 38.84M
Long-Term Investments
89.27M 97.81M 102.51M 62.82M
Other Long-Term Assets
120.61M 94.67M 55.15M 61.26M
Receivables
315.46M 444.38M 419.69M 414.93M
Inventory
33.73M 35.62M 23.55M 10.96M
Other Current Assets
363.18M 50.69M 23.22M 62.74M
Total Current Assets
1.19B 1.49B 1.31B 1.76B
Property-Plant & Equipment
518.15M 521.78M 560.01M 601.51M
Goodwill & Intangibles
967.72M 575.84M 477.41M 463.58M
Total Long-Term Assets
1.92B 1.49B 1.38B 1.35B
Total Assets
3.11B 2.98B 2.69B 3.11B
Account Payables
17.38M 20.93M 14.17M 17.78M
Deferred Revenue
n/a 31.5M 18.59M 18.47M
Short-Term Debt
12.24M 13.63M 13.26M 15.4M
Other Current Liabilities
388.22M 356.17M 231.5M 264.06M
Total Current Liabilities
417.84M 422.23M 277.52M 315.72M
Long-Term Debt
34.75M 37.02M 37.69M 56.72M
Other Long-Term Liabilities
156.38M 108.34M 100.12M 105.31M
Total Long-Term Liabilities
225.88M 185.36M 161.01M 185.74M
Total Liabilities
623.03M 607.58M 438.53M 501.45M
Total Debt
46.99M 50.65M 50.94M 72.12M
Common Stock
n/a 94K 94K 100K
Retained Earnings
2.5B 2.39B 2.3B 2.61B
Comprehensive Income
-19.19M -36.98M -51.64M -10.03M
Shareholders Equity
2.48B 2.36B 2.25B 2.6B
Total Investments
89.27M 236.96M 291.73M 101.66M